Key Takeaways
- Overdose risk peaks right after detox, with opioid overdose rates of 17.3 per 100 person-years for detox discharges versus 5.9-6.6 for later inpatient discharges.
- A real Broward discharge plan locks in a named next appointment within SAMHSA’s 7-day window, medication continuity, naloxone in hand, a behavioral-health visit, and a specific peer contact.
- Compare programs on MOUD access, coordination between SUD and mental-health providers, transportation and housing support, and whether handoffs are warm transfers rather than phone-number referrals.
- Treat aftercare as a 3-to-12-month arc with tapering intensity, and use MHPAEA’s ‘nonquantitative treatment limitation’ language when insurance blocks an authorized level of care.
The First Two Weeks After Detox Are the Fragile Ones
The days immediately following detox are critical for recovery. Your body has cleared the substance, tolerance has dropped, and the nervous system is recalibrating. The coping mechanisms previously used are no longer present.
A retrospective cohort study highlighted this vulnerability: patients discharged after detoxification had an opioid overdose rate of 17.3 per 100 person-years, significantly higher than the 5.9 to 6.6 per 100 person-years for those discharged after later stages of inpatient care. Nearly 10% of detox discharges in the study were followed by an opioid overdose. This indicates that the risk is highest right after discharge.
Therefore, the discharge plan you receive is paramount. The following section details what a comprehensive Broward County discharge plan should include before you leave.

What a Real Broward County Discharge Plan Locks In Before You Walk Out
A discharge packet is merely a folder of phone numbers and meeting lists. A true plan involves scheduled appointments, prescribed medications, and confirmed support systems in place before you leave the facility.
A robust Broward County discharge plan for Day 0 should include:
- A named next appointment with a specific outpatient program, IOP, PHP, or prescriber, scheduled within SAMHSA’s 7-day continuity-of-care window for medically managed withdrawal. This means a confirmed time, not just a number to call.
- Medication continuity, if clinically indicated. For opioid dependence, this requires a bridge dose or an active prescription for buprenorphine, methadone, or naltrexone, as detox alone is insufficient for OUD treatment.
- Naloxone in hand, with a household member trained in its use.
- A separate, coordinated behavioral-health appointment for co-occurring diagnoses such as PTSD, depression, bipolar disorder, or anxiety, ensuring integration rather than disconnected systems.
- A peer contact—a specific individual’s name and number, not a general hotline.
- An insurance and benefits sheet confirming your authorized level of care.
If any of these elements are missing, advocate for them. This ensures the plan functions as intended.

The Discharge-Week Timeline: Day 0 Through Day 30
Day 0 to Day 3: The Handoff, Not the Referral
Day 0 is when you sign discharge paperwork, not when you begin to organize your aftercare. The person driving you home should already know your next appointment details and what to do if you experience difficulties.
During the first 72 hours, the objective is to maintain continuity. This means your outpatient program or prescriber has you on their schedule, not a voicemail list. Your first post-discharge medication dose should be readily available, either in hand or at an accessible pharmacy. Your family member or peer contact should initiate check-ins on Day 1 and Day 2.
Day 4 to Day 14: Hitting the SAMHSA Continuity Windows
SAMHSA evaluates aftercare quality using two specific windows: a qualifying continuity service (outpatient visit, IOP/PHP session, or medication event) within 7 days of discharge, and a second window extending to 14 days. These benchmarks apply to individuals leaving medically managed withdrawal and inpatient/residential SUD treatment. They are federal quality indicators for successful care connection.
Use these windows as a guide. If you reach Day 5 without an appointment, it’s a prompt to act. If Day 10 arrives and your only contact has been a rescheduled intake, your plan is faltering. This period often sees increased cravings, uneven sleep, and a return to household routines. A mid-week check-in with a prescriber or counselor between Day 4 and Day 10 allows for medication adjustments, addressing missed doses, or rescheduling appointments before the 14-day mark passes.
SAMHSA’s measures are administrative, focusing on whether a visit occurred, not its quality or your engagement. Consider the 7- and 14-day marks as minimum requirements, not the ultimate goal.
Day 15 to Day 30: When the Adrenaline Fades
Weeks three and four are often underestimated. The initial urgency of discharge subsides, family members return to work, and the novelty of a new routine wears off. This leaves the more challenging aspect of recovery: maintaining engagement when there’s no immediate crisis.
During this time, plans can quietly unravel. Missed appointments go unrescheduled, prescriptions lapse, and peer contacts are forgotten. These issues may not appear dramatic externally.
Schedule specific check-ins for Day 21 and Day 30, treating them as medical appointments. Inquire about your outpatient program’s re-engagement process for missed sessions; effective programs will proactively reach out. Continuous care thrives on frequent, low-friction contacts, not heroic efforts.
Medication Continuity by Substance: Opioids, Alcohol, Benzodiazepines
Opioids: Why Detox Alone Is the Wrong Endpoint
For individuals with opioid use history, medication is a critical component of the discharge plan. The CDC explicitly states that detoxification without medications for opioid use disorder (MOUD) is not recommended due to increased risks of resumed use, overdose, and overdose death. Your tolerance will have decreased, but the potency of street supply remains high.
Three FDA-approved medications are central to MOUD: methadone, buprenorphine, and naltrexone. SAMHSA views these as integral to a comprehensive recovery plan, complementing counseling and peer support. The choice of medication depends on individual history, access to prescribers or opioid treatment programs, pregnancy status, co-occurring conditions, and personal preference. This decision should be finalized before discharge.
There’s a significant gap in MOUD access; in 2024, only 17.0% of people with opioid use disorder received these medications. This highlights the importance of proactively requesting a bridge prescription if your plan doesn’t include one.
Alcohol: Naltrexone, Acamprosate, and the Quiet Gap
Aftercare for alcohol use disorder (AUD) often receives less attention than opioid aftercare. FDA-approved medications like naltrexone (oral or injectable) and acamprosate are commonly used in Broward outpatient settings, with disulfiram also an option. These medications are not cures but tools to reduce cravings or diminish the reward of drinking, supporting the overall recovery plan.
The treatment gap for AUD is notable: in 2024, only 2.5% of individuals with AUD received medication. If your detox was alcohol-focused and medication wasn’t discussed, raise this with your prescriber at your first outpatient visit. Combine medication with a scheduled behavioral-health follow-up to ensure comprehensive support.
Benzodiazepines: Taper Continuity and Seizure Risk
Benzodiazepine aftercare demands meticulous planning due to the risks involved. Abrupt discontinuation of medications like Xanax, Ativan, Klonopin, or Valium can lead to seizures, and post-detox rebound anxiety and insomnia can trigger relapse. If your medical detox included a benzo taper, it often extends beyond discharge into an outpatient schedule.
Before discharge, ensure you have:
- A named prescriber to manage the remaining taper
- A specific dosing schedule with dates
- A plan for addressing worsening withdrawal symptoms between visits
If you have a co-occurring anxiety disorder or PTSD, the behavioral-health appointment is as crucial as medication management, as underlying symptoms won’t resolve solely with the taper.
The Naloxone Conversation You Should Have Before You Leave
Naloxone is a vital tool that should be readily available. If opioids were part of your substance use history, the CDC recommends that you leave detox with naloxone, especially given the reduced tolerance after abstinence. This applies even if opioids were not your primary substance of use.
Before discharge, ask three key questions:
- Do I have naloxone with me, not just a prescription?
- Does the person picking me up know how to use it, including recognizing an overdose and calling 911?
- Where can I obtain more naloxone if needed, without a doctor’s visit?
The CDC notes that naloxone is available through pharmacies, community programs, and most syringe-services programs, and co-prescription should be discussed with your clinician.
Having naloxone is a safety measure for those around you, ensuring they have a tool if your recovery plan encounters unexpected challenges.
Behavioral Health, Co-Occurring Conditions, and the Second Appointment
If you have a co-occurring mental-health diagnosis—such as PTSD, depression, bipolar disorder, anxiety, ADHD, or a personality disorder—a medication appointment alone is insufficient. A second appointment with a behavioral-health provider who understands the substance use component should be scheduled before you leave.
SAMHSA’s TIP 42 emphasizes that continuity for co-occurring disorders involves regular, adaptable care, reliable provider relationships, coordinated case management, and integrated monitoring of psychiatric and substance-use symptoms. This coordination is not automatic in Broward, where mental-health and SUD systems often operate separately with distinct intake processes and wait times.
At discharge, directly ask who will manage your psychiatric care and when you will see them. If the response suggests your SUD prescriber will handle everything or that you should call around, this indicates a gap. A confirmed behavioral-health visit within the same 14-day window as your SUD follow-up prevents these two crucial aspects of care from becoming disconnected.
Peer Support, Recovery Coaches, and the Broward Community Layer
A peer contact is an essential part of your recovery plan. This individual can provide support when outpatient programs are closed and cravings intensify. SAMHSA defines peer support workers as individuals who leverage their lived experience to help others maintain recovery, extending support beyond clinical settings into daily life.
Clarify the role of a peer or recovery coach at discharge. They are not your prescriber, therapist, or case manager; they will not adjust medication or manage psychiatric care. Instead, they offer practical support, such as checking in on Day 2, accompanying you to a first IOP session, and identifying potential plan weaknesses before you do.
In Broward, peer support can be accessed through outpatient program staff, county human-services access points, or recovery-community organizations. Ensure you leave with a specific name and number, not just a general category.
Insurance, MHPAEA, and the Language That Gets Calls Answered
Insurance calls can impede well-laid plans. The process often involves hold music, unhelpful benefits representatives, and procedural denials. Knowing the right language can streamline this process.
The federal Mental Health Parity and Addiction Equity Act (MHPAEA) was strengthened in September 2024. Final rules from the Departments of Labor, HHS, and Treasury stipulate that plans offering mental-health or substance-use benefits generally cannot impose more restrictive financial or nonquantitative treatment limitations than those applied to comparable medical and surgical benefits, with most provisions effective for plan years beginning on or after January 1, 2025. The key phrase to use is “nonquantitative treatment limitation.” If a plan requires prior authorization for IOP but not for comparable medical step-down care, or applies stricter medical-necessity criteria to buprenorphine than to other maintenance medications, this language will be recognized by reviewers.
Two other strategies are helpful: request the specific clinical criteria being applied and ask for a peer-to-peer review with the prescri if a level of care is denied. It’s important to remember the broader context: in 2024, only 12.3% of people with an SUD received substance-use treatment. Getting your call answered is a significant step in this process.
Fort Lauderdale Logistics: Housing, Transportation, Court, and Family
A discharge plan’s effectiveness is often tested by real-life logistics. Where you live, how you travel to appointments, court obligations, and family dynamics all influence whether follow-up care occurs.
Housing is paramount. If your home environment still contains substances or triggers, address this before Day 0. Sober living options along US-1 and inland can provide a stable bridge between discharge and a permanent, supportive environment; many outpatient programs can help coordinate this. Transportation is another common failure point. A plan requiring multiple bus transfers for an IOP session is unsustainable. Confirm rideshare benefits, inquire about your outpatient program’s transportation options, and map out your route before your first appointment.
Court and probation add specific timelines. If you have a hearing, drug-court check-in, or DCF matter, inform your outpatient program during intake so attendance documentation is properly set up. Family support is crucial; their role should be supportive, not supervisory. This includes sending a Day 2 check-in text, providing a ride to a Day 7 appointment, and knowing where the naloxone is stored. Broward’s Overdose Data to Action program monitors overdose trends, underscoring the importance of local response efforts.
Continuing Care as a 3-to-12-Month Arc, Not an Appointment
The term “aftercare” can be misleading, implying a singular event. Evidence suggests that effective continuing care involves sustained, lower-intensity contacts over several months. A peer-reviewed review of the continuing care model indicates a minimum of 3 months, with contact extending up to 12 months for more durable recovery.
Practically, this means an IOP transitioning to a weekly outpatient group, then to a monthly prescriber check, while maintaining a consistent peer contact. The intensity decreases, but the connection remains. A plan that concludes with a handshake on Day 30 is not true continuing care.
Ask your outpatient program about their engagement plan for months three, six, and twelve. If they lack one, construct your own using existing resources: prescriber, therapist, peer, and family check-ins. The sustained arc of care is the objective.
If You Are the Referring Clinician or Case Manager
For Broward-area clinicians, discharge planners, or case managers benchmarking referral pipelines, two key metrics are crucial: the percentage of discharges with a qualifying continuity service within 7 days, and within 14 days. These SAMHSA measures, while administrative, indicate whether handoffs are warm transfers or mere paper referrals. Supplement these with confirmed MOUD initiation or bridge prescriptions, documented behavioral-health appointments for co-occurring cases, and naloxone dispensed at discharge.

Frequently Asked Questions
How soon after detox should the first follow-up appointment happen in Fort Lauderdale?
The target for the first follow-up appointment is within 7 days, and no later than 14 days. SAMHSA’s continuity-of-care measure for medically managed withdrawal uses these windows as benchmarks for effective care connection. Ensure you have a confirmed date and provider before signing discharge paperwork, rather than just a phone number.
Do I need medication after detox, or is counseling enough?
For opioid use disorder, the CDC explicitly states that detox alone, without medication, is not recommended due to increased risks of resumed use and overdose. Methadone, buprenorphine, and naltrexone are FDA-approved options that work in conjunction with counseling, not as a replacement. For alcohol and other substances, medication may also be beneficial; discuss this before discharge.
Should I leave detox with naloxone even if I don’t use opioids anymore?
Yes, if opioids were ever part of your use history. The CDC specifically identifies individuals with a history of SUD and reduced tolerance after abstinence as those who should be discharged with naloxone. You can also obtain it through pharmacies, community programs, and most syringe-services programs if you need to replace it.
What Broward County resources can help if I don’t have insurance?
Broward Addiction Recovery Center (BARC) serves as the county’s public access point for treatment. The Florida Department of Health’s treatment-and-recovery pathways can guide you to state-funded options, and Broward’s Overdose Data to Action program connects with local prevention resources. Ask your discharge planner to facilitate a warm transfer before you leave, as these are often more efficient than cold referrals.
How long does aftercare actually last?
Aftercare typically lasts longer than most people anticipate. Peer-reviewed literature on continuing care suggests a minimum of 3 months, with contact extending up to 12 months for more sustained recovery. The intensity of care tapers—for example, from IOP to weekly group to monthly prescriber checks—but the connection remains. A plan that involves only one follow-up appointment is not comprehensive aftercare.
What can my family say on the phone to get an insurance plan to authorize continuing care?
Use the phrase “nonquantitative treatment limitation.” The 2024 MHPAEA final rules generally prohibit plans from applying more restrictive limits to mental-health or substance-use benefits than to comparable medical benefits. Ask for the specific clinical criteria being applied and request a peer-to-peer review with the prescriber if a level of care is denied.
References
- Continuity of Care After Medically Managed Withdrawal from Alcohol and/or Drugs (NQF 3312): Technical Specifications and Resource Manual. https://www.samhsa.gov/sites/default/files/cbe-3312-technical-specifications-manual.pdf
- Opioid Use Disorder: Treating | Overdose Prevention. https://www.cdc.gov/overdose-prevention/hcp/clinical-care/opioid-use-disorder-treating.html
- Medications for Opioid Use Disorder. https://www.samhsa.gov/resource/recovery/medications-opioid-use-disorder
- Peer Support Workers for Those in Recovery. https://www.samhsa.gov/substance-use/recovery/peer-support-workers
- Continuity of Care After Inpatient or Residential Treatment for Substance Use Disorder. https://www.samhsa.gov/sites/default/files/cbe-3453-technical-specifications-manual.pdf
- Substance Use Disorder Treatment for People With Co-Occurring Disorders TIP 42. https://library.samhsa.gov/sites/default/files/SAMHSA_Digital_Download/PEP20-02-01-004.pdf
- The Continuing Care Model of Substance Use Treatment. https://pmc.ncbi.nlm.nih.gov/articles/PMC4007701/
- Opioid overdose and inpatient care for substance use disorder: evidence from a retrospective cohort study. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928069/
- CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022. https://stacks.cdc.gov/view/cdc/122248/cdc_122248_DS1.pdf
- Lifesaving Naloxone. https://www.cdc.gov/stop-overdose/caring/naloxone.html
- Treatment and Recovery. https://www.floridahealth.gov/programs-and-services/opioid-response/Overdose_Prevention/TreatmentandRecovery.html
- Overdose Monitoring & Surveillance. https://www.floridahealth.gov/programs-and-services/opioid-response/Overdose_Monitoring/index.html
- Overdose Data to Action-Local. https://broward.floridahealth.gov/programs-and-services/wellness-programs/overdose-data-to-action-local/
- Results from the 2024 National Survey on Drug Use and Health. https://www.samhsa.gov/data/sites/default/files/reports/rpt56287/2024-nsduh-annual-national-report.pdf
- SAMHSA Releases Annual National Survey on Drug Use and Health. https://www.samhsa.gov/newsroom/press-announcements/20250728/samhsa-releases-annual-national-survey-on-drug-use-and-health
- U.S. Overdose Deaths Decrease Almost 27% in 2024. https://www.cdc.gov/nchs/pressroom/releases/20250514.html
- Departments of Labor, Health and Human Services, and Treasury Issue Final Rules Strengthening Access to Mental Health and Substance Use Disorder Care. https://www.cms.gov/newsroom/press-releases/departments-labor-health-and-human-services-treasury-issue-final-rules-strengthening-access-mental




